A study published in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy ...

Medicare Administrative Contractors (MACs), which most Americans have never heard of, pose a perilous hazard to your health.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Racial gaps in the use of ERBB2-targeted therapy among older Medicare beneficiaries with breast cancer reduced significantly ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The best Medicare plans for cancer patients are a Medigap Plan G from AARP and a Medicare Part D plan from Wellcare. Alternatively, if your cancer diagnosis means you can't qualify for Medigap, choose ...

Remote symptom monitoring in cancer care reduces hospitalizations, enhances value-based care, and supports diverse patient ...

Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Medicare Part D changes under the Inflation Reduction Act cap annual out-of-pocket costs for oral cancer drugs at $2,000 starting in 2025, reducing patient expenses by 82–90% for commonly used ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Tribal officials and some congressional leaders say cuts to federal health programs have not included input from Native ...

Enrollment in Medicare coverage without out-of-pocket protections was associated with a higher likelihood of reporting cost and access barriers to care.